Gene · 53335
Papers3,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deoxyribonucleic Acid 5-Hydroxymethylation in Cell-Free Deoxyribonucleic Acid, a Novel Cancer Biomarker in the Era of Precision Medicine. | Front Cell Dev Biol | 2021 | 34957093 | PubTator, text mining | PubMed |
| Induced Pluripotent Stem Cells (iPSCs) and Gene Therapy: A New Era for the Treatment of Neurological Diseases. | Int J Mol Sci | 2021 | 34948465 | PubTator, text mining | PubMed |
RNA Sequencing of Primary Cutaneous and Breast-Implant Associated Anaplastic Large Cell Lymphomas Reveals Infrequent Fusion Transcripts and Upregulation of PI3K/AKT Signaling via Neurotrophin Pathway Genes. | Cancers (Basel) | 2021 | 34944796 | PubTator, text mining | PubMed |
| Therapeutic Targeting of Exportin-1 in Childhood Cancer. | Cancers (Basel) | 2021 | 34944778 | PubTator, text mining | PubMed |
| MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets. | Biomedicines | 2021 | 34944633 | PubTator, text mining | PubMed |
| Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences. | Cells | 2021 | 34944094 | PubTator, text mining | PubMed |
| CRISPR-Based Approaches for the High-Throughput Characterization of Long Non-Coding RNAs. | Noncoding RNA | 2021 | 34940760 | PubTator, text mining | PubMed |
| High Expression of BCL11A Predicts Poor Prognosis for Childhood MLL-r ALL. | Front Oncol | 2021 | 34938655 | PubTator, text mining | PubMed |
| Transcriptomics of single dose and repeated carbon black and ozone inhalation co-exposure highlight progressive pulmonary mitochondrial dysfunction. | Part Fibre Toxicol | 2021 | 34911549 | PubTator, text mining | PubMed |
| CRISPR/Cas System and Factors Affecting Its Precision and Efficiency. | Front Cell Dev Biol | 2021 | 34901007 | PubTator, text mining | PubMed |
| β-Thalassemia: evolving treatment options beyond transfusion and iron chelation. | Hematology Am Soc Hematol Educ Program | 2021 | 34889443 | PubTator, text mining | PubMed |
| Gene Editing in Pluripotent Stem Cells and Their Derived Organoids. | Stem Cells Int | 2021 | 34887928 | PubTator, text mining | PubMed |
| A Novel Germline Heterozygous BCL11B Variant Causing Severe Atopic Disease and Immune Dysregulation. | Front Immunol | 2021 | 34887873 | PubTator, text mining | PubMed |
| A network-based method for predicting disease-associated enhancers. | PLoS One | 2021 | 34879086 | PubTator, text mining | PubMed |
| MiR-155-5p suppresses SOX1 to promote proliferation of cholangiocarcinoma via RAF/MEK/ERK pathway. | Cancer Cell Int | 2021 | 34876142 | PubTator, text mining | PubMed |
| BAF155 methylation drives metastasis by hijacking super-enhancers and subverting anti-tumor immunity. | Nucleic Acids Res | 2021 | 34865122 | PubTator, text mining | PubMed |
| Multiplex CRISPR/Cas9 genome editing in hematopoietic stem cells for fetal hemoglobin reinduction generates chromosomal translocations. | Mol Ther Methods Clin Dev | 2021 | 34853798 | PubTator, text mining | PubMed |
| Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management. | J Pers Med | 2021 | 34834454 | PubTator, text mining | PubMed |
| Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies. | Cells | 2021 | 34831472 | PubTator, text mining | PubMed |
| Dynamic Variations of 3'UTR Length Reprogram the mRNA Regulatory Landscape. | Biomedicines | 2021 | 34829789 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53335/papers?page=48